home / stock / vero / vero news

VERO News and Press, Venus Concept Inc. From 05/12/22

Stock Information
Company Name: Venus Concept Inc.
Stock Symbol: VERO
Market: NYSE
Website: venusconcept.com
Menu
VERO VERO Quote VERO Short VERO News VERO Articles VERO Message Board
Get VERO Alerts

News, Short Squeeze, Breakout and More Instantly...
VERO - Venus Concept Inc. (VERO) CEO Dom Serafino on Q1 2022 Results - Earnings Call Transcript

Venus Concept Inc. (VERO) Q1 2022 Earnings Conference Call May 12, 2022, 05:00 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Conference Call Participants Marie Thibault - BTIG Jeffrey Cohen - Ladenburg Thalmann Jon Block - Stifel An...
VERO - Venus Concept GAAP EPS of -$0.13 misses by $0.04, revenue of $26.41M misses by $0.6M

Venus Concept press release (NASDAQ:VERO): Q1 GAAP EPS of -$0.13 misses by $0.04. Revenue of $26.41M (+16.9% Y/Y) misses by $0.6M. The Company continues to expect total revenue for the twelve months ending December 31, 2022 in the range of $126 million to $130 million, representing an increas...

VERO - Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three months ended March 31, 2022. First Quarter 2022 Summa...

VERO - Notable earnings after Thursday's close

AAIC, ACB, ACHV, AFRM, AGRO, AGRX, APDN, APTX, AQN, AVPT, AXU, BANX, BBI, BEAT, BIOL, BLBD, BLND, BOXL, BSQR, CBAY, CDXC, CLLS, CLVR, CODX, COMP, CORZ, CRMD, CTIC, CURI, CWCO, DARE, DUOL, EDR, ETON, EYEN, FIGS, GPL, GWH, HLI, HTGM, IBIO, IDN, OTCQB:IGXT, IMMR, INDI, INTZ, INUV, JOBY, KMPH, LC...
VERO - ANIX and CPS among mid-day movers

Gainers: GTY Technology Holdings (GTYH) +114%. Vaxxinity (VAXX) +57%. Zymeworks (ZYME) +35%. Redbox Entertainment (RDBX) +33%. Finch Therapeutics Group (FNCH) +29%. Opiant Pharmaceuticals (OPNT) +29%. Puyi (PUYI) +27%. Cyngn (CYN) +24%. Clearwater (CLW) +24%. Anixa Biosciences (ANIX) +21%. Lo...

VERO - Finch, Zymeworks top healthcare gainers; while Accolade, Aldeyra leads losers' pack

Gainers: Finch Therapeutics (FNCH) +46%. Zymeworks (ZYME) +44%. Lantheus (LNTH) +13%. BeiGene (BGNE) +12%. Inari Medical (NARI) +11%. Losers: Accolade (ACCD) -55%. Aldeyra Therapeutics (ALDX) -15%. Venus Concept (VERO) -14%. Bio...

VERO - Venus Concept jumps on expanded FDA clearance for BlissMAX

The shares of MedTech company Venus Concept (NASDAQ:VERO) have added ~20% in the post-market Thursday after announcing it received the 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Venus BlissMAX device for further indication. BlissMAX is designed to offer la...
VERO - Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX

TORONTO, April 28, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received a 510(k) clearance from the U.S. Food and Drug Administration (&#x...

VERO - Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime(TM) Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that the first patient has been treated in a U.S. Investigational Device Exemption (IDE...

VERO - Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quarter of fiscal year 2022 financial results will be released after the mar...
Previous 10 Next 10